Cargando…
Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma
BACKGROUND: Mantle cell lymphoma (MCL) is an aggressive disease with short median survival. Molecularly, MCL is defined by the t(11;14) translocation leading to overexpression of the CCND1 gene. However, recent data show that the neural transcription factor SOX11 is a disease defining antigen and se...
Autores principales: | Emruli, Venera Kuci, Olsson, Roger, Ek, Fredrik, Ek, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949756/ https://www.ncbi.nlm.nih.gov/pubmed/27430213 http://dx.doi.org/10.1186/s12885-016-2550-4 |
Ejemplares similares
-
Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk
por: Lokhande, Lavanya, et al.
Publicado: (2020) -
Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma
por: Lokhande, Lavanya, et al.
Publicado: (2021) -
Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity
por: Freiburghaus, Catja, et al.
Publicado: (2018) -
DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells
por: Nordström, Lena, et al.
Publicado: (2015) -
SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study
por: Nordström, Lena, et al.
Publicado: (2014)